Our Services
Medical Information
Helpful Resources
Published on: 9/15/2026
Pregabalin causes dizziness because it binds to calcium channels in the central nervous system, calming overactive nerve signaling in a way that also slows balance, coordination, and blood pressure regulation, especially during the first days of treatment or after a dose increase. Higher doses, rapid titration, alcohol, older age, kidney problems, and other sedating medicines such as opioids, gabapentin, or antihistamines can make the spinning, unsteady, or lightheaded feeling much stronger. Many people find it fades within one to two weeks as the body adapts, but persistent dizziness, fainting, blurred vision, swelling, or worsening confusion can signal a dose or interaction issue that needs medical review, and stopping suddenly carries its own risks. There are several important factors, dosing considerations, and warning signs to weigh, so see below to understand more before changing anything about your medication.
If dizziness is disrupting your walking, driving, or daily routine, it helps to know whether this is an expected adjustment effect or something that needs prompt attention, and a free, instant, online symptom check can help you sort your symptoms, spot red flags, and prepare clear questions for your prescriber in just a few minutes.
Last reviewed for medical accuracy: 09/15/2026
Dizziness is one of the most commonly reported side effects of pregabalin, a medication widely used to treat nerve pain, epilepsy and generalized anxiety disorder. If you’ve started pregabalin and found yourself feeling lightheaded or unsteady, you’re not alone. Understanding why pregabalin causes dizziness and what you can do to manage it can help you stay safe and comfortable.
Pregabalin is an analogue of the neurotransmitter GABA (gamma-aminobutyric acid), but it does not bind directly to GABA receptors. Instead, it:
By slowing down overactive nerve signals, pregabalin helps relieve symptoms—but this same mechanism can also slow normal nerve activity, leading to dizziness.
Dizziness with pregabalin arises mainly from its central nervous system (CNS) depressant effects. Key factors include:
CNS Depression
• Slowed nerve transmission can make it harder for your brain to process balance and spatial orientation signals.
• Similar to how alcohol or sedatives affect coordination, pregabalin may cause lightheadedness.
Dose-Related Effect
• Higher doses are more likely to cause dizziness.
• Rapid dose increases can overwhelm your body’s ability to adapt.
Individual Sensitivity
• Older adults may be more prone to dizziness because of age-related changes in drug metabolism and balance.
• Reduced kidney function can lead to higher pregabalin levels, intensifying side effects.
Interaction with Other Medicines
• Combining pregabalin with opioids, benzodiazepines, antihistamines or alcohol can amplify CNS depression and dizziness.
Clinical trials and prescribing information report dizziness in about 30–50% of patients taking pregabalin. In most cases, the dizziness is mild to moderate and improves after a few weeks as your body adjusts.
While some dizziness may be unavoidable, these practical steps can help you reduce its intensity and impact:
Start Low, Go Slow
• Begin with the lowest effective dose.
• Increase dose gradually as directed by your doctor.
Take at Night
• If your schedule allows, take pregabalin before bedtime to sleep through peak dizziness.
Rise Slowly
• When getting up from lying or sitting, pause for 10–15 seconds before standing.
Stay Hydrated
• Dehydration can worsen dizziness. Aim for 6–8 glasses of water per day, unless your doctor tells you otherwise.
Avoid Alcohol and Other Sedatives
• Alcohol and sleep aids can compound dizziness and impair coordination.
Monitor Your Environment
• Keep walkways clear of obstacles and use supportive footwear.
• Consider handrails or a walker if your balance is significantly affected.
Plan Your Day
• Schedule important activities (driving, operating machinery) at times of day when dizziness is least severe.
Most dizziness from pregabalin improves over time, but you should speak to a doctor if you experience:
If you have worrying symptoms, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Pregabalin can be a highly effective treatment for certain types of chronic pain, seizures and anxiety. When comparing benefits against side effects:
Weigh Pain Relief vs. Dizziness
• If pregabalin significantly reduces your pain or seizure frequency, mild dizziness may be a worthwhile trade-off.
• If dizziness severely impacts daily activities, your doctor may adjust your dose or suggest an alternative.
Regular Reviews
• Keep a symptom diary noting dose, time of day, dizziness severity and other side effects.
• Share this with your healthcare provider to guide dosing decisions.
Alternative Therapies
• Non-drug approaches—such as physical therapy, cognitive behavioral therapy or acupuncture—may complement or reduce the need for higher pregabalin doses.
Always discuss any concerning side effects or new symptoms with your healthcare provider. Before making changes to how you take pregabalin:
If you ever experience life-threatening or serious symptoms—such as severe breathing difficulties, chest pain, intense dizziness leading to fainting or major allergic reactions—seek medical attention immediately. Speak to a doctor if you’re ever in doubt about your symptoms or medication plan.
By understanding why pregabalin can make you dizzy and taking proactive steps to manage it, you can get the therapeutic benefits while minimizing discomfort. Always work closely with your healthcare team to find the safest and most effective treatment plan for your needs.
(References)
* Keller R. Une place pour la prégabaline dans le traitement de la sciatique ?. Rev Med Suisse. 2017 mai 10;13(562):1020. PMID: 28631444.
* Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev. 2019 Jan 23;1(1):CD007076. doi: 10.1002/14651858.CD007076.pub3. Epub 2019 Jan 23. PMID: 30673120; PMCID: PMC6353204.
* Park CY, Park SH, Lim DG, Choi EK. Effect of preoperative pregabalin on postoperative pain after gastrectomy. Yeungnam Univ J Med. 2018 Jun;35(1):40-44. doi: 10.12701/yujm.2018.35.1.40. Epub 2018 Jun 30. PMID: 31620569; PMCID: PMC6784661.
* Kharasch ED, Clark JD, Kheterpal S. Perioperative Gabapentinoids: Deflating the Bubble. Anesthesiology. 2020 Aug;133(2):251-254. doi: 10.1097/ALN.0000000000003394. PMID: 32667153; PMCID: PMC7367437.
* Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, Rajbhandari S, Sharma S, Rayman G, Gouni R, Alam U, Cooper C, Loban A, Sutherland K, Glover R, Waterhouse S, Turton E, Horspool M, Gandhi R, Maguire D, Jude EB, Ahmed SH, Vas P, Hariman C, McDougall C, Devers M, Tsatlidis V, Johnson M, Rice ASC, Bouhassira D, Bennett DL, Selvarajah D, OPTION-DM trial group. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. Lancet. 2022 Aug 27;400(10353):680-690. doi: 10.1016/S0140-6736(22)01472-6. Epub 2022 Aug 22. PMID: 36007534; PMCID: PMC9418415.
* Ishikawa R, Iseki M. [Pharmacological Treatment of Trigeminal Neuralgia]. No Shinkei Geka. 2024 Jan;52(1):63-69. doi: 10.11477/mf.1436204880. PMID: 38246671.
* Guo X, Zhang T, Yuan G, Zeng W, Hu Q, Ma J, Li Y, Li H, Zhang Y, Liu J, Bian F, Zhang W, Zhang F, Pang S, Li Y, Wu X, Tang X, Zhang K, Pan T, Hu H, Cheng Z, Wang Y, Gao J, Sun J. GABA Analogue HSK16149 in Chinese Patients With Diabetic Peripheral Neuropathic Pain: A Phase 3 Randomized Clinical Trial. JAMA Netw Open. 2024 Aug 1;7(8):e2425614. doi: 10.1001/jamanetworkopen.2024.25614. Epub 2024 Aug 1. PMID: 39158916; PMCID: PMC11333976.
* Shi Y, Song C. Effectiveness and Safety of Gabapentin versus Pregabalin in the Treatment of Postherpetic Neuralgia: A Retrospective Cohort Study. Br J Hosp Med (Lond). 2024 Dec 30;85(12):1-11. doi: 10.12968/hmed.2024.0485. Epub 2024 Dec 9. PMID: 39831496.
* Yaukey J, Kaur D. Management of Small Fiber Neuropathy: A Clinical Perspective. Muscle Nerve. 2026 Mar;73(3):380-384. doi: 10.1002/mus.70086. Epub 2025 Dec 10. PMID: 41367223.
* Salvi R, Wang TC, Eddins A. Hyperacusis-inducing drug candidates. Hear Res. 2026 Jul;477:109673. doi: 10.1016/j.heares.2026.109673. Epub 2026 May 14. PMID: 42143865.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.